India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six dosage strengths. The once-weekly injector, known as Mounjaro KwikPen, now covers doses ranging from 2.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.